A. Mohamed

Selenium nanoparticles and quercetin suppress thioacetamide‐induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement

A. Abdelghany, R. A. Zaghloul, Amal M. El Gayar, 2022, Journal of biochemical and molecular toxicology.

Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors

N. Abdel-Hamid, Shimaa A Abass, Ahmed A Mohamed, 2018, Biomedicine & Pharmacotherapy.

Factors Affecting Treatment Outcome of Metastatic Breast Cancer: Single Institution Study

N. Ibrahim, A. Mohamed, Sara shamsaldin, 2023, Open Access Macedonian Journal of Medical Sciences.

New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study

Abdullah A. Elgazar, D. G. Parambi, S. N. Bukhari, 2023, Journal of enzyme inhibition and medicinal chemistry.

MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection

R. Ahmed, A. Khater, A. Mohamed, 2020, Journal of translational internal medicine.

Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery

M. Ghoneim, M. M. Al-Sanea, Sarah M. Albogami, 2021, Life.

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights

Abdullah A. Elgazar, M. A. Bhat, N. Ziedan, 2023, Journal of enzyme inhibition and medicinal chemistry.